East Bay biotech giant to cut 530 jobs, add 325 in restructuring By: San Francisco Business Times via Business Journals February 04, 2021 at 11:08 AM EST The biotech tools company, whose shareholders include BlackRock Inc., said the phased restructuring will cost $125 million to $130 million. Read More >>
